Weighing the Risk and Benefits of Patent Disputes
Jilted Drugs Are Joining Candidate Databases Hoping for a Match
The Myriad Decisions Have Not Been a Death Knell for the Biotechnology Industry
Cosmos Offers Unique Microgravity Environment for Life Science Research
Chemically Defined Media Achieve Consistency, not Universality—Not without Supplements
Single-Use, Hollow Fibers Cannot Transition from Small-Scale Processes to Large-Scale Production Fast Enough
Be sure to add firstname.lastname@example.org
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2015 Genetic Engineering & Biotechnology News All Rights Reserved